BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 34657281)

  • 1. Calcium channel blockers versus other classes of drugs for hypertension.
    Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD003654. PubMed ID: 34657281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blockers versus other classes of drugs for hypertension.
    Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD003654. PubMed ID: 35000192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Chen YJ; Li LJ; Tang WL; Song JY; Qiu R; Li Q; Xue H; Wright JM
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008170. PubMed ID: 30480768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line diuretics versus other classes of antihypertensive drugs for hypertension.
    Reinhart M; Puil L; Salzwedel DM; Wright JM
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD008161. PubMed ID: 37439548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockers for hypertension.
    Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers versus other classes of drugs for hypertension.
    Chen N; Zhou M; Yang M; Guo J; Zhu C; Yang J; Wang Y; Yang X; He L
    Cochrane Database Syst Rev; 2010 Aug; (8):CD003654. PubMed ID: 20687074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line drugs for hypertension.
    Wright JM; Musini VM; Gill R
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD001841. PubMed ID: 29667175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension.
    Wang GM; Li LJ; Tang WL; Wright JM
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012569. PubMed ID: 33089502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evening versus morning dosing regimen drug therapy for hypertension.
    Wu C; Zhao P; Xu P; Wan C; Singh S; Varthya SB; Luo SH
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD004184. PubMed ID: 38353289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure targets in adults with hypertension.
    Arguedas JA; Leiva V; Wright JM
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004349. PubMed ID: 33332584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
    Martin N; Manoharan K; Davies C; Lumbers RT
    Cochrane Database Syst Rev; 2021 May; 5(5):CD012721. PubMed ID: 34022072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
    Li EC; Heran BS; Wright JM
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blockers for people with chronic kidney disease requiring dialysis.
    Mugendi GA; Mutua FM; Natale P; Esterhuizen TM; Strippoli GF
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011064. PubMed ID: 33000470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for hypertension-induced left ventricular hypertrophy.
    Leache L; Gutiérrez-Valencia M; Finizola RM; Infante E; Finizola B; Pardo Pardo J; Flores Y; Granero R; Arai KJ
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD012039. PubMed ID: 34628642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for hypertension in adults 60 years or older.
    Musini VM; Tejani AM; Bassett K; Puil L; Wright JM
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD000028. PubMed ID: 31167038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockers for hypertension.
    Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Mbewu A; Opie LH
    Cochrane Database Syst Rev; 2012 Nov; 11():CD002003. PubMed ID: 23152211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.
    Abalos E; Duley L; Steyn DW; Gialdini C
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD002252. PubMed ID: 30277556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.